ATP5D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.068600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.763400E-01
Normal-vs-Stage2
4.593600E-01
Normal-vs-Stage3
8.549200E-01
Normal-vs-Stage4
7.691800E-01
Stage1-vs-Stage2
5.225600E-01
Stage1-vs-Stage3
3.047400E-01
Stage1-vs-Stage4
2.758200E-01
Stage2-vs-Stage3
4.880800E-01
Stage2-vs-Stage4
4.933000E-01
Stage3-vs-Stage4
9.899200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.591000E-01
Normal-vs-AfricanAmerican
5.995400E-01
Normal-vs-Asian
7.077600E-02
Caucasian-vs-AfricanAmerican
5.401200E-01
Caucasian-vs-Asian
1.792430E-01
AfricanAmerican-vs-Asian
1.299610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.167800E-01
Normal-vs-Female
3.314800E-01
Male-vs-Female
1.265040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.202000E-01
Normal-vs-Age(41-60Yrs)
4.946600E-01
Normal-vs-Age(61-80Yrs)
4.281600E-01
Normal-vs-Age(81-100Yrs)
7.942200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.858400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.817200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.479400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.578600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.851600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.670200E-01
Normal-vs-Daily Drinker
3.001000E-01
Normal-vs-Weekly Drinker
6.445700E-02
Normal-vs-Occasional Drinker
4.799400E-01
Normal-vs-Social Drinker
3.274200E-01
Non Drinker-vs-Daily Drinker
1.916980E-01
Non Drinker-vs-Weekly Drinker
2.360200E-01
Non Drinker-vs-Occasional Drinker
7.737200E-01
Non Drinker-vs-Social Drinker
8.260000E-01
Daily Drinker-vs-Weekly Drinker
6.532000E-01
Daily Drinker-vs-Occasional Drinker
1.986190E-01
Daily Drinker-vs-Social Drinker
1.729430E-01
Weekly Drinker-vs-Occasional Drinker
2.126200E-01
Weekly Drinker-vs-Social Drinker
2.152800E-01
Occasional Drinker-vs-Social Drinker
9.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.312600E-01
Normal-vs-Grade 2
7.892800E-01
Normal-vs-Grade 3
7.066400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.850580E-01
Grade 1-vs-Grade 3
1.300190E-01
Grade 1-vs-Grade 4
8.312600E-01
Grade 2-vs-Grade 3
5.922000E-01
Grade 2-vs-Grade 4
7.892800E-01
Grade 3-vs-Grade 4
7.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.867200E-01
Normal-vs-NonDiabetic
3.246400E-01
Diabetic-vs-NonDiabetic
5.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.369200E-01
Normal-vs-NoPancreatitis
3.749400E-01
Pancreatitis-vs-NoPancreatitis
2.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.300000E-01
Normal-vs-N1
5.108400E-01
N0-vs-N1
6.320200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.134000E-01
Normal-vs-TP53-NonMutant
5.836800E-01
TP53-Mutant-vs-TP53-NonMutant
8.934000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
